Sarah Cannon Research Institute Implements Virtify CTRR

           Sarah Cannon Research Institute Implements Virtify CTRR

Clinical Trial Disclosure Solution Improves Compliance, Productivity, Cost
Savings

PR Newswire

LEXINGTON, Mass., July 15, 2013

LEXINGTON, Mass., July 15, 2013 /PRNewswire/ -- Virtify, Inc., a leading
innovator in content and regulatory information management solutions for the
life science industry, today announced that Sarah Cannon Research Institute
(SCRI), a wholly owned subsidiary of HCA, has signed an enterprise-level
contract for its Clinical Trial Registration & Results (CTRR) disclosure
software. SCRI will utilize Virtify's CTRR to disclose their clinical trial
information to the National Institute of Health's clinicaltrials.gov system as
mandated by federal regulation.

(Logo: http://photos.prnewswire.com/prnh/20110131/NE38689LOGO )

The old paradigm for managing disclosure throughout the clinical trial process
has changed, including at academic and research organizations. Many now
recognize that the large number of disparate, investigator-driven studies at
these institutions, coupled with constant updates to these studies and
increasingly complex disclosure requirements, render manual processes too
cumbersome and error-prone.

"Sarah Cannon Research Institute is pleased to partner with Virtify to help
automate the clinical trial disclosure processes within the SCRI Services
Organization in order to fulfill its regulatory requirements," said Sheetal
Khedkar, M.D., M.S.P.H, Director for Pharmacovigilance, Medical Writing and
Scientifics at SCRI. "Virtify CTRR will help automate registration and results
posting, significantly reducing the effort it takes to publish the trial
information to clinicaltrials.gov."

Virtify's CTRR software helps streamline and automate the mandatory
registration and results disclosure postings to the clinicaltrials.gov website
and to other registries. The software also has the ability to provide a
compliance view across all studies at an institution, allowing for better
reporting and proactive compliance. Virtify's CTRR software offers
academic/research institutions the most complete overall solution for managing
compliance with regulatory reporting requirements including supporting
integrations to "Off the Shelf" or custom applications.

"Virtify's CTRR system will enable SCRI to comply with clinical disclosure
requirements in an efficient, consistent and predictable manner," said Satish
Tadikonda, President and CEO of Virtify, Inc. "Simultaneously, Virtify CTRR
will help streamline and optimize their disclosure activities, resources, and
time. This increases business efficacy and productivity. The ability of
Virtify CTRR to communicate with other SCRI systems means that duplicate data
entry can be eliminated as well."

About SCRI

Sarah Cannon Research Institute (SCRI) is a global strategic research
organization focusing on advancing therapies for patients. It is one of the
largest clinical research programs, conducting community-based clinical trials
in oncology and cardiology through affiliations with a network of more than
700 physicians in the United States and United Kingdom. Additionally, SCRI
offers management, regulatory and other research support services to drug
development sponsors and strategic investigator sites. SCRI is a wholly owned
subsidiary of HCA. For more information, please visit
http://sarahcannonresearch.com/

About Virtify

Virtify is the leading innovator in content and regulatory information
management solutions for life sciences. Many of the world's leading
organizations rely on Virtify solutions to reduce time-to-market, risk, and
costs by managing and automating the complex regulatory compliance and content
exchange requirements throughout the product life cycle. Virtify's life
science domain expertise has been leveraged by such companies as
Genzyme/Sanofi, Novartis, Pfizer/Wyeth, Regeneron, academic research centers
and CROs. Virtify's easy-to-use software suite is the industry's only
solution to provide a secure, collaborative, web-based environment for
managing regulated content throughout the entire continuum – from pre-clinical
through product registration to commercialization. Visit us at
http://www.virtify.com

SOURCE Virtify, Inc.

Website: http://www.virtify.com
Contact: Eric Meyers, Virtify, Inc., 617-301-8710, emeyers@virtify.com